University College London begins preclinical studies to develop a

NexTGen: Next Generation T Cell Therapies for Childhood Cancers

Frontiers The Limitless Future of RNA Therapeutics

University College London begins preclinical studies to develop a treatment for Niemann Pick C disease with support from the Columbus Foundation – Columbus Children's Foundation

Preclinical Drug Development Process, Preclinical Trials

A stroke recovery trial development framework: Consensus-based core recommendations from the Second Stroke Recovery and Rehabilitation Roundtable - Julie Bernhardt, Kathryn S Hayward, Numa Dancause, Natasha A Lannin, Nick S Ward, Randolph

NIH puts hold on $30 million trial of potential stroke drug, Science

University College London begins preclinical studies to develop a treatment for Niemann Pick C disease with support from the Columbus Foundation – Columbus Children's Foundation

NovalGen receives CTA approval to start a Phase 1/2 first in human study to evaluate the safety, pharmacokinetics and efficacy of NVG-111 in Chronic Lymphocytic Leukemia & Mantle Cell Lymphoma - 07 - 04 - 2021 - UCLB

Cells, Free Full-Text

Cells, Free Full-Text